Zetia (Ezetimibe) Antitrust v. Merck & Company, Incorporated

Docket(#45) ORDER filed granting Motion to extend filing time [ # 42 ]. Number of days granted: 11. Reply brief due 02/23/2021. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Copies to all parties. [1000861410] [20-2184] JR [Entered: 12/08/2020 09:00 AM]

Docket(#44) APPEARANCE OF COUNSEL by Erin C. Burns for FWK Holdings, LLC. [1000858104] [20-2184] Erin Burns [Entered: 12/02/2020 11:24 AM]

Docket(#43) RESPONSE/ANSWER by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc. to Motion [ # 42 ]. Nature of response: in opposition. [20-2184] William Monroe [Entered: 12/01/2020 01:44 PM]

Docket(#42) MOTION by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to extend filing time for reply brief until February 23, 2021.. Date and method of service: 11/30/2020 ecf. [1000856267] [20-2184] Daniel Adler [Entered: 11/30/2020 08:06 PM]

Docket(#41) OBJECTION to DOCKETING STATEMENT by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc.. [20-2184] David Sorensen [Entered: 11/30/2020 06:43 PM]

Docket(#40) Corrected Customized BRIEFING ORDER filed -- FRAP 30(c) Schedule. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Page-Proof Opening Brief due: 01/04/2021. Page-Proof Response Brief due: 02/02/2021. Appendix under FRAP 30(c) due: 02/05/2021. All Briefs in Final Form due 7 days after FRAP 30(c) Appendix served. [20-2184] AB [Entered: 11/24/2020 02:59 PM]

Docket(#39) (ENTRY RESTRICTED) Customized BRIEFING ORDER filed -- FRAP 30(c) Schedule. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Page-Proof Opening Brief due: 01/04/2021. Page-Proof Response Brief due: 02/02/2021. Appendix under FRAP 30(c) due: 02/16/2021. All Briefs in Final Form due 7 days after FRAP 30(c) Appendix served. [20-2184]--[Edited 11/24/2020 by AB] AB [Entered: 11/24/2020 02:55 PM]

Docket(#38) ORDER filed granting Motion to proceed with a deferred appendix [ # 36 ]. Copies to all parties. [1000854400] [20-2184] AB [Entered: 11/24/2020 02:44 PM]

Docket(#37) ORDER filed rescinding accelerated briefing order. Copies to all parties. [1000854396] [20-2184] AB [Entered: 11/24/2020 02:42 PM]

Docket(#36) MOTION by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to proceed with a deferred appendix. Date and method of service: 11/23/2020 ecf. [1000853348] [20-2184] Daniel Adler [Entered: 11/23/2020 02:00 PM]

Docket(#10) APPEARANCE OF COUNSEL by Daniel R. Adler for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847552] [20-2184] Daniel Adler [Entered: 11/13/2020 02:00 PM]

Docket(#9) APPEARANCE OF COUNSEL by Theodore J. Boutrous, Jr. for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847544] [20-2184] Theodore Boutrous [Entered: 11/13/2020 01:48 PM]

Docket(#8) RESPONSE/ANSWER by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to Motion [ # 6 ], Motion [ # 6 ], notice requesting response [ # 7 ]. Nature of response: in opposition. [20-2184] Theodore Boutrous [Entered: 11/13/2020 01:45 PM]

Docket(#7) NOTICE ISSUED to Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., MSP Singapore Co. LLC, Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, Schering Corporation and Schering Plough Corporation requesting response to Motion to accelerate case processing [ # 6 ], Motion to expedite decision [ # 6 ]Response due 11/23/2020.[1000846507]. [20-2184] AW [Entered: 11/12/2020 11:06 AM]

Docket(#6) MOTION by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc. to accelerate case processing. , to expedite decision. Date and method of service: 11/11/2020 ecf. [1000846035] [20-2184] William Monroe [Entered: 11/11/2020 04:08 PM]

Docket(#5) APPEARANCE OF COUNSEL by William H. Monroe, Jr. for Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc.. [1000846033] [20-2184] William Monroe [Entered: 11/11/2020 03:55 PM]

Docket(#4) DOCKETING NOTICE issued Re: [ # 1 ] case Originating case number: 2:18-md-02836-RBS-DEM. [20-2184] JR [Entered: 11/04/2020 03:00 PM]

Docket(#3) FEE NOTICE issued to Mr. Theodore J. Boutrous, Jr., Esq., Mr. Christopher D. Dusseault, Jennifer L. Eaton, R. Brendan Fee, Zachary M. Johns, Mr. Stephen Edward Noona, Richard Hooper Ottinger, Dustin Mitchell Paul, Steven A. Reed, Jessica J. Taticchi - after grant of permission to appeal Originating case number: 2:18-md-02836-RBS-DEM. [20-2184] JR [Entered: 11/04/2020 02:59 PM]

Docket(#2) Case transferred from miscellaneous docket 20-432. Record complete? Yes. [20-2184] TF [Entered: 11/02/2020 02:16 PM]

Docket(#1) Case docketed. Originating case number: 2:18-md-02836-RBS-DEM. Case manager: JRice. [20-2184] TF [Entered: 11/02/2020 02:10 PM]